Milvexian shows potential to reduce risk of ischemic stroke
A phase 2 trial in patients with a prior ischemic stroke or high-risk transient ischemic attack (TIA) has indicated that milvexian should be further investigated for its ability to reduce the risk of ischemic stroke without ...
Aug 29, 2022
0
14